FiercePharmaOriginal article
{"a":[{"_":"FDA drops warning letter on Bausch & Lomb, citing contamination concerns","$":{"href":"/manufacturing/fda-drops-warning-letter-bausch-lomb-contamination-concerns","hreflang":"en"}}]}
RegulatoryEye medications (prescription and OTC)Negative
AI Analysis
Summary
The FDA issued a warning letter to Bausch & Lomb regarding contamination concerns at its Tampa, Florida facility that manufactures prescription and over-the-counter eye medications. The action reflects regulatory scrutiny of the company's manufacturing practices and quality control.
Outcome Details
Warning letter issued for contamination concerns at Tampa, Florida manufacturing facility
Importance:6/10
Sentiment:
-0.80
regulatorymanufacturingcontaminationwarning lettercomplianceeye care
Related Companies
Read the original article
Published by FiercePharma on September 17, 2026 7:52 AM